Can CD44 Be a Mediator of Cell Destruction? The Challenge of Type 1 Diabetes
| Autor: | David Naor, Lola Weiss, Itamar Raz, Talya Weiss, Dror Sever, Ariel Ginzberg, Sharon Perles, Elimelech Okon, Nathalie Assayag-Asherie, Pamela Y. Johnson, Lora Eshkar Sebban, Marika Bogdani, Eva A. Turley |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Cell lcsh:Medicine Inflammation Apoptosis Mice Cell Movement Internal medicine Insulin-Secreting Cells medicine Animals Hyaluronic Acid lcsh:Science Receptor NOD mice Type 1 diabetes Multidisciplinary biology Pancreatic islets Insulin lcsh:R CD44 Biological Transport medicine.disease Endocrinology medicine.anatomical_structure Diabetes Mellitus Type 1 Glucose Hyaluronan Receptors Gene Expression Regulation biology.protein lcsh:Q Female medicine.symptom Research Article |
| Zdroj: | PLoS ONE PLoS ONE, Vol 10, Iss 12, p e0143589 (2015) |
| ISSN: | 1932-6203 |
| Popis: | CD44 is a multi-functional receptor with multiple of isoforms engaged in modulation of cell trafficking and transmission of apoptotic signals. We have previously shown that injection of anti-CD44 antibody into NOD mice induced resistance to type 1 diabetes (T1D). In this communication we describe our efforts to understand the mechanism underlying this effect. We found that CD44-deficient NOD mice develop stronger resistance to T1D than wild-type littermates. This effect is not explained by the involvement of CD44 in cell migration, because CD44-deficient inflammatory cells surprisingly had greater invasive potential than the corresponding wild type cells, probably owing to molecular redundancy. We have previously reported and we show here again that CD44 expression and hyaluronic acid (HA, the principal ligand for CD44) accumulation are detected in pancreatic islets of diabetic NOD mice, but not of non-diabetic DBA/1 mice. Expression of CD44 on insulin-secreting β cells renders them susceptible to the autoimmune attack, and is associated with a diminution in β-cells function (e.g., less insulin production and/or insulin secretion) and possibly also with an enhanced apoptosis rate. The diabetes-supportive effect of CD44 expression on β cells was assessed by the TUNEL assay and further strengthened by functional assays exhibiting increased nitric oxide release, reduced insulin secretion after glucose stimulation and decreased insulin content in β cells. All these parameters could not be detected in CD44-deficient islets. We further suggest that HA-binding to CD44-expressing β cells is implicated in β-cell demise. Altogether, these data agree with the concept that CD44 is a receptor capable of modulating cell fate. This finding is important for other pathologies (e.g., cancer, neurodegenerative diseases) in which CD44 and HA appear to be implicated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|